Item 5.07. Submission of Matters to a Vote of Security Holders.

Protagenic Therapeutics, Inc. (the "Company") held its 2020 Annual Meeting of Stockholders (the "Annual Meeting") on October 6, 2020. Holders of an aggregate of 10,261,419 shares of the Company's Common Stock at the close of business on August 14, 2020 were entitled to vote at the Annual Meeting, of which 6,500,561 shares were present in person or represented by proxy. At the Annual Meeting, the Company's stockholders voted as follows:





Proposal One: The stockholders elected each of the following individuals as a
director for a one year term expiring on the date of the Company's 2021 Annual
Meeting of Stockholders and until their successors have been duly elected and
qualified.



Name                   For          Against      Withheld      Broker Non-Votes
Garo H. Armen        6,389,927           0           176                   -
Robert B. Stein      6,389,925           0           178                   -
Khalil Barrage       6,389,931           0           172                   -
Brian J. Corvese     6,389,930           0           173                   -
Joshua Silverman     6,389,932           0           168                   -
Jennifer Buell       6,389,937           0           166                   -

Proposal Two: The stockholders ratified the selection of MaloneBailey LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.





   For      Against   Abstain
6,500,483     58        20














  2

© Edgar Online, source Glimpses